MINOCIN IV
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $4,512 | 23 | 21 |
| 2017 | $261,286 | 5,095 | 1,891 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $109,911 | 4,961 | 41.4% |
| Honoraria | $69,900 | 38 | 26.3% |
| Consulting Fee | $44,198 | 7 | 16.6% |
| Travel and Lodging | $25,434 | 91 | 9.6% |
| Unspecified | $8,949 | 5 | 3.4% |
| Space rental or facility fees (teaching hospital only) | $7,350 | 8 | 2.8% |
| Education | $55.52 | 8 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RETROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE UTILIZATION, OUTCOMES, AND ADVERSE EVENTS IN PARTICIPANTS TREATED WITH MINOCIN MINOCYCLINE FOR INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA IN A REAL WORLD SETTING | The Medicines Company | $8,949 | 0 |
Top Doctors Receiving Payments for MINOCIN IV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Critical Care Medicine | Augusta, GA | $30,273 | 42 |
| Frank Cutaia | — | Houston, TX | $27,587 | 17 |
| , MD | Infectious Disease | Huntsville, AL | $22,857 | 39 |
| , MD | Pulmonary Disease | Washington, DC | $15,535 | 5 |
| , M.D | Pulmonary Disease | Phoenix, AZ | $8,326 | 18 |
| , M.D | Infectious Disease | Shreveport, LA | $6,139 | 16 |
| , MD | Specialist | Pittsburgh, PA | $5,654 | 2 |
| , DO | Pulmonary Disease | Los Angeles, CA | $4,464 | 5 |
| , MD | Emergency Medicine | Southfield, MI | $4,094 | 9 |
| , M.D | Infectious Disease | Victoria, TX | $3,526 | 12 |
| , MD | Pulmonary Disease | Las Vegas, NV | $3,247 | 28 |
| , M.D | Emergency Medicine | Waukesha, WI | $3,219 | 8 |
| , MD | Infectious Disease | Cookeville, TN | $3,189 | 9 |
| , M.D | Emergency Medicine | Houston, TX | $2,932 | 8 |
| , M.D | Infectious Disease | San Antonio, TX | $2,852 | 18 |
| , M.D | Infectious Disease | Grand Rapids, MI | $2,609 | 8 |
| , MD | Critical Care Medicine | Phoenix, AZ | $2,451 | 9 |
| , M.D | Internal Medicine | Livingston, NJ | $2,291 | 6 |
| , MD | Infectious Disease | Memphis, TN | $2,168 | 8 |
| , M.D | Infectious Disease | Santa Monica, CA | $2,093 | 4 |
| , M.D | Internal Medicine | Detroit, MI | $2,015 | 6 |
| , MD | Infectious Disease | Newark, NJ | $1,937 | 4 |
| , MD | Infectious Disease | Shenandoah, TX | $1,935 | 18 |
| , MD | Internal Medicine | Whitesburg, KY | $1,826 | 4 |
| , MD | Infectious Disease | Webster, TX | $1,450 | 4 |
Manufacturing Companies
- The Medicines Company $265,797
Product Information
- Type Drug
- Total Payments $265,797
- Total Doctors 1,898
- Transactions 5,118
About MINOCIN IV
MINOCIN IV is a drug associated with $265,797 in payments to 1,898 healthcare providers, recorded across 5,118 transactions in the CMS Open Payments database. The primary manufacturer is The Medicines Company.
Payment data is available from 2017 to 2018. In 2018, $4,512 was paid across 23 transactions to 21 doctors.
The most common payment nature for MINOCIN IV is "Food and Beverage" ($109,911, 41.4% of total).
MINOCIN IV is associated with 1 research study, including "A RETROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE UTILIZATION, OUTCOMES, AND ADVERSE EVENTS IN PARTICIPANTS TREATED WITH MINOCIN MINOCYCLINE FOR INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA IN A REAL WORLD SETTING" ($8,949).